Health Care & Life Sciences » Pharmaceuticals | Ascendis Health Ltd.

Ascendis Health Ltd. | Income Statement

Fiscal year is July-June. All values ZAR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
598
1,618
2,817
3,914
6,435
7,737
Cost of Goods Sold (COGS) incl. D&A
353
890
1,625
2,351
3,622
4,267
Gross Income
245
728
1,191
1,563
2,813
3,469
SG&A Expense
183
550
781
1,025
1,744
2,111
EBIT
-
-
-
-
848
1,359
Unusual Expense
-
-
12
146
169
91
Non Operating Income/Expense
8
68
27
41
15
380
Interest Expense
55
55
100
163
296
343
Pretax Income
7
185
293
235
442
561
Income Tax
5
45
83
51
63
68
Equity in Affiliates
-
1
1
6
1
3
Consolidated Net Income
1
139
210
190
378
496
Net Income
9
136
210
159
354
471
Net Income After Extraordinaries
9
137
210
159
425
664
Net Income Available to Common
9
136
210
159
283
277
EPS (Basic)
0.09
0.63
0.79
0.56
0.69
0.60
Basic Shares Outstanding
104
215
267
281
412
462
EPS (Diluted)
0.09
0.63
0.79
0.56
0.69
0.60
Diluted Shares Outstanding
104
215
267
281
412
462
EBITDA
60
178
414
538
1,055
1,630
Other Operating Expense
15
33
57
79
221
-
Non-Operating Interest Income
7
26
24
44
44
16
Minority Interest Expense
-
8
2
31
24
25

About Ascendis Health

View Profile
Address
31 Georgian Crescent East
Johannesburg GT 2191
South Africa
Employees -
Website http://ascendishealth.com
Updated 07/08/2019
Ascendis Health Ltd. engages in the manufacture and distribution of medical and health products. It operates through the following segments: Consumer Brands, Phyto-Vet, and Pharma-Med. The Consumer Brands segment includes TC medicines, vitamins, sports nutrition and skin care products.